A Public Health Action Plan To Combat Antimicrobial Resistance (Part I: Domestic Issues): Meeting for Public Comment on the Antimicrobial Resistance Interagency Task Force Annual Report, 21265 [E7-8158]

Download as PDF Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices additives, Food additives, Pesticides and pests, Reporting and recordkeeping requirements. Mary W. Dove, Secretary of the Commission. [FR Doc. 07–2138 Filed 4–26–07; 2:57 pm] Dated: April 18, 2007. Janet L. Andersen, Director, Biopesticides and Pollution Prevention Division, Office of Pesticide Programs. BILLING CODE 6715–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. E7–8179 Filed 4–27–07; 8:45 am] BILLING CODE 6560–50–S Centers for Disease Control and Prevention FEDERAL COMMUNICATIONS COMMISSION Sunshine Act Meeting Schedule Change; Open Commission Meeting, April 25, 2007 April 25, 2007. The Federal Communications Commission previously announced its intention to hold an Open Meeting on Wednesday, April 25, 2007 at 9:30 a.m. The meeting has been postponed until 6:45 p.m. The prompt and orderly conduct of the Commission’s business requires this change and no earlier announcement was practicable. Federal Communications Commission. Marlene H. Dortch, Secretary. Editorial Note: This document was received at the Office of the Federal Register on April 26, 2007. [FR Doc. 07–2119 Filed 4–26–07; 12:47 pm] BILLING CODE 6712–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meeting Notices DATE AND TIME: Thursday, May 3, 2007, at 10 a.m. 999 E Street, NW., Washington, DC (Ninth Floor). PLACE: This Meeting will be Open to the Public. STATUS: rwilkins on PROD1PC63 with NOTICES ITEMS TO BE DISCUSSED: Correction and Approval of Minutes. Advisory Opinion 2007–05: Erik Iverson by counsel, Donald F. McGahn, II. Advisory Opinion 2007–06: Libertarian Party of Indiana by Todd Singer, Treasurer. Notice of Proposed Rulemaking on Hybrid Ads. Management and Administrative Matters. VerDate Aug<31>2005 18:27 Apr 27, 2007 PERSON TO CONTACT FOR INFORMATION: Mr. Robert Biersack, Press Officer, Telephone: (202) 694–1220. Jkt 211001 A Public Health Action Plan To Combat Antimicrobial Resistance (Part I: Domestic Issues): Meeting for Public Comment on the Antimicrobial Resistance Interagency Task Force Annual Report The Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Institutes of Health (NIH) announce an open meeting concerning antimicrobial resistance. Name: A Public Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues): Meeting for Public Comment on the Antimicrobial Resistance Interagency Task Force Annual Report. Times and Dates: 11:30 a.m.–12:30 p.m., Wednesday, June 27, 2007. Place: Hyatt Regency Bethesda, Bethesda, Maryland, One Bethesda Metro Center (7400 Wisconsin Ave), Bethesda, Maryland, USA 20814; Tel: 1– 301–652–2000; Fax: 1–301–652–4525). Status: Open to the public, limited only by the space available. Purpose: To present the annual report of progress by Federal agencies in accomplishing activities outlined in A Public Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues) and solicit comments from the public regarding the annual report. The Action Plan serves as a blueprint for activities of Federal agencies to address antimicrobial resistance. The focus of the plan is on domestic issues. Matters To Be Discussed: The agenda will consist of welcome and introductory comments, an executive summary, and brief reports in four focus areas: Surveillance, Prevention and Control, Research, and Product Development. The meeting will then be open for general discussion. Comments and suggestions from the public for Federal agencies related to each of the focus areas will be taken under advisement by the Antimicrobial Resistance Interagency Task Force. The PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 21265 agenda does not include development of consensus positions, guidelines, or discussions or endorsement of specific commercial products. The Action Plan, Annual Report, and meeting agenda are available at https:// www.cdc.gov/drugresistance. The public meeting is sponsored by the CDC, FDA, and NIH in collaboration with seven other Federal agencies and departments that were involved in developing and writing A Public Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues). Agenda items are subject to change as priorities dictate. Limited time will be available for oral questions, comments, and suggestions from the public. Depending on the number wishing to comment, a time limit of three minutes may be imposed. In the interest of time, visual aids will not be permitted, although written material may be submitted for subsequent review by the Task Force. Written comments and suggestions from the public are encouraged and should be received by the contact person or email listed below prior to the opening of the meeting or no later than the end of July 2007. Persons anticipating attending the meeting are requested to send written notification to the contact person below by June 21, 2007, including name, organization (if applicable), address, phone, fax, and e-mail address. Contact Person for More Information: Marsha A. Jones, Office of Antimicrobial Resistance, CCID/CDC, Mailstop A–07, 1600 Clifton Road, NE., Atlanta, GA 30333; telephone 404–639–4111; fax 404–639–7444. Dated: April 23, 2007. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention (CDC). [FR Doc. E7–8158 Filed 4–27–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Epidemiological Studies of Epilepsy, Potential Extramural Project 2007–R– 05 Correction: This notice was published in the Federal Register on April 9, 2007, Volume 72, Number 67, page 17555. The meeting was originally scheduled as a teleconference. In lieu of a E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 72, Number 82 (Monday, April 30, 2007)]
[Notices]
[Page 21265]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-8158]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


A Public Health Action Plan To Combat Antimicrobial Resistance 
(Part I: Domestic Issues): Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report

    The Centers for Disease Control and Prevention (CDC), Food and Drug 
Administration (FDA), and National Institutes of Health (NIH) announce 
an open meeting concerning antimicrobial resistance.
    Name: A Public Health Action Plan to Combat Antimicrobial 
Resistance (Part I: Domestic Issues): Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report.
    Times and Dates: 11:30 a.m.-12:30 p.m., Wednesday, June 27, 2007.
    Place: Hyatt Regency Bethesda, Bethesda, Maryland, One Bethesda 
Metro Center (7400 Wisconsin Ave), Bethesda, Maryland, USA 20814; Tel: 
1-301-652-2000; Fax: 1-301-652-4525).
    Status: Open to the public, limited only by the space available.
    Purpose: To present the annual report of progress by Federal 
agencies in accomplishing activities outlined in A Public Health Action 
Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues) and 
solicit comments from the public regarding the annual report. The 
Action Plan serves as a blueprint for activities of Federal agencies to 
address antimicrobial resistance. The focus of the plan is on domestic 
issues.
    Matters To Be Discussed: The agenda will consist of welcome and 
introductory comments, an executive summary, and brief reports in four 
focus areas: Surveillance, Prevention and Control, Research, and 
Product Development. The meeting will then be open for general 
discussion.
    Comments and suggestions from the public for Federal agencies 
related to each of the focus areas will be taken under advisement by 
the Antimicrobial Resistance Interagency Task Force. The agenda does 
not include development of consensus positions, guidelines, or 
discussions or endorsement of specific commercial products.
    The Action Plan, Annual Report, and meeting agenda are available at 
https://www.cdc.gov/drugresistance. The public meeting is sponsored by 
the CDC, FDA, and NIH in collaboration with seven other Federal 
agencies and departments that were involved in developing and writing A 
Public Health Action Plan to Combat Antimicrobial Resistance (Part I: 
Domestic Issues).
    Agenda items are subject to change as priorities dictate.
    Limited time will be available for oral questions, comments, and 
suggestions from the public. Depending on the number wishing to 
comment, a time limit of three minutes may be imposed. In the interest 
of time, visual aids will not be permitted, although written material 
may be submitted for subsequent review by the Task Force. Written 
comments and suggestions from the public are encouraged and should be 
received by the contact person or email listed below prior to the 
opening of the meeting or no later than the end of July 2007.
    Persons anticipating attending the meeting are requested to send 
written notification to the contact person below by June 21, 2007, 
including name, organization (if applicable), address, phone, fax, and 
e-mail address.
    Contact Person for More Information: Marsha A. Jones, Office of 
Antimicrobial Resistance, CCID/CDC, Mailstop A-07, 1600 Clifton Road, 
NE., Atlanta, GA 30333; telephone 404-639-4111; fax 404-639-7444.

    Dated: April 23, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention 
(CDC).
 [FR Doc. E7-8158 Filed 4-27-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.